We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
(+16%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
10.5%
Top 10 Holdings %
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.11M |
| 3 |
Nike
NKE
|
+$1.03M |
| 4 |
PAY
Verifone Systems Inc
PAY
|
+$959K |
| 5 |
MON
Monsanto Co
MON
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.43M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.19M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.41M |
| 4 |
Enterprise Products Partners
EPD
|
+$1.02M |
| 5 |
Magna International
MGA
|
+$933K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.63% |
| 2 | Healthcare | 14.32% |
| 3 | Technology | 11.92% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Haemonetics
HAE
$3.58B
| $276K | 0.18% |
+7,900
| New | +$255K |
|
|
DO
252
DELISTED
Diamond Offshore Drilling
DO
| $276K | 0.18% |
12,700
-100
| -0.8% | -$1.97K |
|
253
KeyCorp
KEY
$24.3B
| $275K | 0.18% |
+24,900
| New | +$278K |
|
254
Vornado Realty Trust
VNO
$7.47B
| $274K | 0.18% |
3,587
+618
| +21% | +$44.8K |
|
|
EFOR
255
Everforth Inc
EFOR
$845M
| $273K | 0.18% |
+7,400
| New | +$261K |
|
256
SAP
SAP
$187B
| $273K | 0.18% |
+3,400
| New | +$265K |
|
257
Fidelity National Information Services
FIS
$21.5B
| $272K | 0.18% |
+4,300
| New | +$258K |
|
258
MillerKnoll
MLKN
$1.5B
| $272K | 0.18% |
+8,800
| New | +$234K |
|
|
TIVO
259
DELISTED
Tivo Inc
TIVO
| $269K | 0.18% |
+13,100
| New | +$260K |
|
|
BNCL
260
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $268K | 0.18% |
+19,600
| New | +$253K |
|
|
AVG
261
DELISTED
AVG Technologies N.V.
AVG
| $268K | 0.18% |
+12,900
| New | +$242K |
|
262
Revvity
RVTY
$12.3B
| $267K | 0.18% |
5,400
-7,000
| -56% | -$334K |
|
|
IPHI
263
DELISTED
INPHI CORPORATION
IPHI
| $267K | 0.18% |
+8,000
| New | +$214K |
|
|
BWLD
264
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $267K | 0.18% |
+1,800
| New | +$275K |
|
|
TWTR
265
DELISTED
Twitter, Inc.
TWTR
| $265K | 0.18% |
+16,000
| New | +$280K |
|
266
Hormel Foods
HRL
$13.9B
| $264K | 0.18% |
+6,100
| New | +$254K |
|
|
WWAV
267
DELISTED
The WhiteWave Foods Company
WWAV
| $264K | 0.18% |
+6,500
| New | +$247K |
|
|
B
268
Barrick Mining
B
$62.2B
| $263K | 0.18% |
+19,400
| New | +$226K |
|
269
C.H. Robinson
CHRW
$22B
| $260K | 0.17% |
3,500
| – | – |
|
|
VISN
270
Vistance Networks Inc
VISN
$2.66B
| $260K | 0.17% |
9,300
-4,800
| -34% | -$116K |
|
271
Advanced Drainage Systems
WMS
$10.9B
| $260K | 0.17% |
+12,200
| New | +$251K |
|
272
NorthWestern Energy
NWE
$4.48B
| $259K | 0.17% |
+4,200
| New | +$242K |
|
273
Boyd Gaming
BYD
$6.47B
| $258K | 0.17% |
+12,500
| New | +$221K |
|
274
Constellation Brands
STZ
$22.2B
| $257K | 0.17% |
+1,700
| New | +$246K |
|
275
Grupo Cibest SA
CIB
$20.4B
| $256K | 0.17% |
+7,500
| New | +$223K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q1 2016 Portfolio in Review
As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.
- Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
- Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
- Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
- Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
- Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
- Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
- Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.
Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.